Esqueceu sua senha? Está inadimplente? Consulte nossa política de anistia

Linhas de pesquisa

Roadmap for New Opportunities in Melanoma Resarch
Society for Melanoma Research (SMR) and Melanoma Research Foundation (MRF)

A. Basic Research

Melanoma Classification

Melanocyte Development and Transformation

Melanoma Resistance to Genotoxic Stimuli

Tumor Microenvironment

Metastasis

Animal Models

Immune Responses

Serum Diagnostics

B. Clinical Research

Overview

New Strategies for Characterization, Monitoring, and Therapy

Clinical Research Infrastructure

Development of the Melanoma Working Group

C. Epidemiology and Prevention

General Population Studies

Familial Studies

Molecular demiology Studies

Genetic Studies in Families

Challenges, Opportunities, and Priorities

D. Training

Overview

Long-Term Objectives

Short-Term Objectives

WORKING GROUPS

Basic Research

Ze ev Ronai (Chair), Burnham Institute, La Jolla, CA
Menashe Bar-Eli, M.D. Anderson Cancer Center, University of Texas, Houston, TX
Anja Bosserhoff, Institute of Pathology, University of Regensburg, Germany
David E. Fisher, Dana Farber Cancer Institute, Harvard University, Boston, MA
Oystein Fodstad, Institute for Cancer Research, University of South Alabama, Birmingham, AL
Ruth Halaban, Yale University School of Medicine, New Haven, CT
Ingegerd Hellstroem, Department of Pathology, University of Washington, Seattle, WA
Karl-Erik Hellstroem, Department of Pathology, University of Washington, Seattle, WA

Clinical Research

Lynn Schuchter (Chair), Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Michael B. Atkins, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA
Paul B. Chapman, Memorial Sloan-Kettering Cancer Center, New York, NY
Alexander M.M. Eggermont, Erasmus University Medical Center, Rotterdam, The Netherlands
Elisabeth A. Grimm, University of Texas, M.D. Anderson Cancer Center, Houston, TX
John M. Kirkwood, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Vernon K. Sondak, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
Jeffrey S. Weber, Norris Cancer Center, University of Southern California, Los Angeles, CA

Epidemiology and Prevention

Marianne Berwick (Chair), University of New Mexico, Albuquerque, NM
Nicholas K. Hayward, Queensland Institute of Medical Research, Brisbane, Australia
Randy Lomax, Melanoma Research Foundation, Princeton, NJ
Williams (Bill) R. Marsch, Melanoma Research Foundation, Princeton, NJ
Julia A. Newton-Bishop, St. James University Hospital, Leeds, United Kingdom
Kate O Neill, Foundation for Melanoma Research, Philadelphia, PA
Timothy R. Rebbeck, University of Pennsylvania, Philadelphia, PA
Nancy Thomas, University of North Carolina, Chapel Hill, NC

Training

Daniel Pinkel (Chair), Comprehensive Cancer Center, University of California, San Francisco, CA
Elisabeth Grimm, M.D. Anderson Cancer Center, University of Texas, Houston, TX
Meenhard Herlyn, Wistar Institute, Philadelphia, PA
Thomas S. Kupper, Dana Farber Cancer Institute, Harvard University, Boston, MA
Jeffrey Trent, Translational Genomics Research Institute, Phoenix, AZ

Área ainda em construção

X